YABAO PHARM.CORP
6003516.470.94% ( +0.06 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: YABAO PHARM.CORP(600351) the Revenue is 572.02 M (-6.92%);the EBIT is 135.8 M (+4.36%);the EPS is 0.154 (+1.25%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.57B6.92%
----
----
EBIT
0.14B4.36%
----
----
EPS
0.15411.25%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf